ZOMBIE COMPANY REPORT
The Growth You Already Own
How a stalled B2B company decides what its existing assets could become
01 / OVERVIEW
Overview
When growth stalls, the first question is what the company can profitably do with assets it already owns.
A capability customers rely on, useful customer knowledge, permitted IP, distribution, a delivery process or an established relationship can be the starting point. Find what is underused, build a commercial opportunity around it, then choose the route to market.
The thesis
Most companies do not have a growth idea problem. They have an asset utilization problem. This is the operating thesis we test, not a prevalence estimate established by the research below. Partnership thinking helped reveal it: relationships can create a route to market, but the opportunity begins inside the company.
Four paths to evaluate
- Restart it. Fix the current growth constraint when customer value and delivery economics still support the offer.
- Narrow it. Focus on a buyer, problem and scope that can be sold and delivered profitably.
- Commercialize it differently. Use a new offer, channel, license, bundle, customer expansion, distribution relationship, referral system, direct sale or partnership where the economics support it.
- Sell, license or close it. Explore another owner or use for the assets, or orderly closure, when continued operation lacks a credible case.
For founders and investors in US B2B companies with $1M to $10M in annual revenue, paying customers and persistent weak growth, including bootstrapped businesses and those funded no later than seed. A financing gap alone does not establish the condition.
02 / WHY WAITING GETS COSTLY
More funding does not mean easier access
In 2025, companies on Carta raised more capital than the year before while completing 41% fewer funding rounds than at the 2021 peak. A recovery in total dollars can coexist with concentrated investment and fewer rounds. It does not establish what a particular company can raise.[1]
| Published measure | Reported result | Scope and period |
|---|---|---|
| Capital raised | $119.5 billion, up 16.9% from 2024 | Companies on Carta, 2025 [1] |
| Funding rounds | 4,859, the lowest annual count in at least six years | Companies on Carta, 2025 [1] |
| AI share of capital | More than 60% | Companies on Carta, Q1 2026 [2] |
| Very large seed rounds | $2.8 billion of $12 billion in rounds of at least $100 million | Crunchbase global seed data, Q2 2026 [4] |
The final row is roughly 23% of global seed dollars in that quarter, calculated as $2.8 billion divided by $12 billion. It measures dollars, not the share of companies receiving funding.[4]
The cost of waiting
When growth stalls and cash keeps leaving, each month spent on a plan that is not improving the business leaves less room to test another. A new round can buy time, but the operating plan has to explain what that time will change.
An old funding announcement is weak evidence of distress. Some companies choose to operate without another round; others raise privately or report late. Customer demand, retention, delivery costs and cash needs provide a better basis for the decision.
Keep the populations separate
Bootstrapped does not mean seed funded. Venture debt does not change an equity funding stage; repayment obligations still belong in the review. Crunchbase’s seed and angel category also includes certain unclassified venture rounds, equity crowdfunding and convertible notes of $3 million or less.[4] Carta and Crunchbase cover different populations and periods, not a matched company cohort.
03 / RECOGNIZE THE CONDITION
Recognize the operating condition
We use “zombie operating condition” narrowly: a business keeps running while persistent weak growth and spending commitments leave no credible route to a sustainable next stage. It describes an operating condition, not a public diagnosis or a judgment of the founder.
When a closer review is useful
- Revenue growth has remained weak or negative for six to twelve months.
- There is limited evidence that more sales activity alone will materially improve acquisition.
- Ongoing burn, delivery commitments or financing pressure are narrowing the options.
- Retention, usage or customer outcomes suggest some assets remain valuable.
- There is no clearly funded, credible plan for sustainable growth.
When the label may not fit
- The business is intentionally small and profitable.
- Seasonality or a few long contracts distort the apparent revenue trend.
- A temporary execution bottleneck is clearly identified and its remedy is funded.
- Current operating evidence supports a defined path to profitability.
Read the records together
Review revenue, renewals, usage, pipeline, collections and delivery costs over six to twelve months, or longer where needed. Ask why customers stay, buy or leave. Confirm who has the authority, resources and willingness to change the plan. Interest, unpaid pilots and a large pipeline do not establish paid customer value.
Keep the market evidence in perspective
SaaS Capital’s 2026 survey of more than 1,000 private B2B SaaS companies reported median 2025 growth of 22%, versus 25% for 2024. Just 7.3% reported flat or negative growth, compared with 6.9% previously.[3]
These respondents span different sizes and funding histories. The figures do not measure seed-company failure rates or the prevalence of strategic plateaus.
04 / FIND THE UNDERUSED ASSET
Find the underused asset
Bring customers, operators or advisers into an asset review. Ask what they rely on, what would be hard to replace, and where else the capability could help. Get examples. The founder does not need to arrive with the answer.
| Area | Question to answer |
|---|---|
| Asset | What does the company already possess that is valuable and underused? |
| Specific problem | Which costly or recurring problem could it solve? |
| Buyer and decision owner | Who values that outcome, who pays, and who can approve a test? |
| Economics | What remains after selling, implementation, support and any route-specific costs? |
| Market test | What bounded action would support or reject the commercial case? |
The earlier report called this an Unfair Advantage Audit and used ASSET as a question set. The purpose remains asset discovery and disciplined commercial testing; none of the questions requires a partnership.
A case from earlier work
An insurance technology company already had an offer and commercial capability. We refined its rollout strategy and offer positioning, and brought on a BDR to book and handle appointments. Live sales activity began within roughly two and a half weeks. Over the following three months, the company generated more than $250,000 in additional revenue. Our contribution was positioning and sales execution; other factors contributed.
This is our anonymized account, not an independently verified result or proof of a repeatable outcome from the new Intensive. It illustrates an existing capability finding a clearer commercial path.
Choose the route after the opportunity
Compare direct sale, customer expansion, a new offer, licensing, distribution and other feasible routes. A partnership can be useful when another business brings necessary access or capability on workable terms. Where others must participate, confirm contributions, authority, economics and timing before building.
Reject or revise an opportunity when buyers do not recognize the problem, rights or permissions are missing, a required participant will not act, or delivery consumes the margin. Access to a customer list does not establish demand.
05 / TEST AND DECIDE
Test and decide
Use this proposed 30-day sequence to evaluate one opportunity. Set the budget and decision date before starting. This general learning sequence is not the Intensive delivery clock or a promise that a sale closes within a month.
Days 1 through 7: choose the test
Review the operating record, surface assets and choose one commercial use worth testing. Compare it with improving the current offer. Define the buyer, route, economics, owner and the evidence that would disprove the idea.
Days 8 through 14: launch and ask
Put the defined opportunity in front of the market. Present a price and limited scope when appropriate. Ask what matters, who decides and what must happen next. A paid pilot or purchase is stronger evidence than praise or an introduction; a launched test does not guarantee either.
Days 15 through 30: review the evidence
Deliver a small paid scope when the sales cycle allows. Track cash collected, customer results, delivery hours and direct costs. If procurement remains open, record the sponsor, evaluation and dated decision process as intermediate evidence. Do not count it as revenue.
| Path | Evidence to justify the next move |
|---|---|
| Restart | Customer value remains; fixing a specific constraint improves acquisition or delivery economics. |
| Narrow | A defined buyer values a clearer scope with workable delivery costs. |
| Commercialize differently | The selected route reaches demand and can support viable delivery. Required participants can act. |
| Sell, license or close | The operating case remains weak; assess demand for assets and attached obligations. |
When selling or closing deserves examination
Inventory what another owner could use, such as software, permitted data, customer contracts or specialist capabilities. Review ownership and outstanding commitments with your accountant and attorney. Give the decision an owner and a date, including how customers and employees will be supported.
One successful test earns the next. Repeat purchases, renewals and repeatable delivery provide stronger evidence. Where evidence is incomplete, name the remaining question and cap the time and money spent resolving it.
06 / SOURCES AND METHOD
Sources and method
This is an evidence review and practitioner perspective, not a census of stalled businesses. Funding databases have coverage gaps and reporting delays; surveys may reflect response and survivorship bias. The asset review and testing sequence are proposed decision tools, not a measured turnaround formula.
The source review was prepared September 21, 2026. This September 24 revision broadens the commercialization framing, aligns the case account with the current offer and retains the research populations and periods. It does not retrospectively describe every prior engagement as a partnership.
- Carta. State of Private Markets 2025 in Review. February 18, 2026.
- Carta. State of Private Markets Q1 2026. May 29, 2026.
- SaaS Capital. 2026 Private B2B SaaS Growth Rate Benchmarks. 2026 survey of 2025 growth.
- Crunchbase News. Global Startup Investment Hit Record $510B in H1 2026. July 2, 2026; data July 1.
About Rylie Hicks
Rylie Hicks is Founder and President of Hicks Enterprises and the founder of Trapped Growth. Rylie spent years building and exiting service businesses by finding more value in the customers, capabilities, relationships and infrastructure already in place. He has since applied the same lens across B2B companies to reposition offers, uncover new commercial paths and contribute to measurable revenue growth.
Explore the growth already inside your company
Read more and explore the Trapped Growth Intensive. Trapped Growth Live examines one company and one underused asset every Tuesday at noon Mountain Time. Submit your company or join the discussion.
This report is for general informational purposes only and is not legal, tax, accounting, investment or financial advice. Businesses considering a sale, license, financing, restructuring or closure should consult appropriate professional advisers.